Medical Device Manufacturing and Sterilization

The contract involves the manufacture of sterile, FDA-compliant Class II vascular sheath introducers equipped with a guidewire and radiopaque marker, fully compliant with Good Manufacturing Practices and requiring a 36-month shelf life. All production must meet stringent regulatory and quality standards to ensure safety and efficacy for clinical use, with sterilization processes validated and documented to maintain compliance throughout the product lifecycle. The devices are intended for surgical applications and must be produced in a controlled environment that adheres to FDA and international medical device regulations. This is a subcontract under the Department of Defense’s Medical Supply Chain initiative, with performance based at FPO, ZIP 09566-4008. The solicitation, identified under NAICS code 325620 for pharmaceutical and medicine manufacturing, was posted on July 30, 2026, with a response deadline of August 5, 2026. The contracting entity is the U.S. military medical supply system, indicating the end-use is for defense medical services. While specific volume or pricing details are not included, the technical and regulatory demands imply a high-barrier entry requiring certified facilities, validated sterilization methods, and documented quality control systems capable of supporting long-term supply chain reliability.